色素-话题@MedSci

#色素#

654篇内容 | 6184人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680491, encodeId=44fa168049168, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Nature：PD-1免疫疗法再掀高潮！罕见黑色素瘤完全缓解近1/3！, objectType=article, longId=126473, objectId=2e6d1264e3de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e6d1264e3de, replyNumber=0, likeNumber=76, createdTime=2018-09-11, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e6d1264e3de, moduleTitle=Nature：PD-1免疫疗法再掀高潮！罕见黑色素瘤完全缓解近1/3！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e6d1264e3de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680476, encodeId=ede816804e6ab, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Eur J Ophthalmol：双侧色素黄斑病和前段发育不良的罕见病例！, objectType=article, longId=122806, objectId=4e1212280615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1212280615, replyNumber=0, likeNumber=67, createdTime=2018-03-20, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1212280615, moduleTitle=Eur J Ophthalmol：双侧色素黄斑病和前段发育不良的罕见病例！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e1212280615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680438, encodeId=6e311680438e8, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：黑色素瘤PD-L1表达：不同免疫组化抗体间的比较, objectType=article, longId=111292, objectId=a2f6111292d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2f6111292d7, replyNumber=0, likeNumber=88, createdTime=2017-12-29, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2f6111292d7, moduleTitle=CLIN CANCER RES：黑色素瘤PD-L1表达：不同免疫组化抗体间的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2f6111292d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680399, encodeId=7b1b1680399b2, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=BJC：鼻腔粘膜黑色素瘤治疗新手段！, objectType=article, longId=98716, objectId=c7b398e164b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7b398e164b, replyNumber=0, likeNumber=54, createdTime=2018-01-17, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7b398e164b, moduleTitle=BJC：鼻腔粘膜黑色素瘤治疗新手段！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7b398e164b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680442, encodeId=08ee1680442d0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Transl Oncol：BTYNB或是黑色素瘤和卵巢癌新的治疗靶点, objectType=article, longId=112458, objectId=6aaa1124582c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aaa1124582c, replyNumber=0, likeNumber=82, createdTime=2017-10-11, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aaa1124582c, moduleTitle=Transl Oncol：BTYNB或是黑色素瘤和卵巢癌新的治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aaa1124582c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680485, encodeId=105516804857b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=EUR J Cancer：Pembrolizumab治疗晚期黑色素瘤后使用伊匹单抗/nivolumab治疗的风险较低, objectType=article, longId=125181, objectId=e829125181d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e829125181d4, replyNumber=0, likeNumber=61, createdTime=2018-03-05, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e829125181d4, moduleTitle=EUR J Cancer：Pembrolizumab治疗晚期黑色素瘤后使用伊匹单抗/nivolumab治疗的风险较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e829125181d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680448, encodeId=48e61680448aa, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Am Acad Dermatol：皮肤镜能提高非色素性皮肤癌的诊断和管理, objectType=article, longId=114563, objectId=7a28114563b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a28114563b1, replyNumber=0, likeNumber=46, createdTime=2017-12-25, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a28114563b1, moduleTitle=J Am Acad Dermatol：皮肤镜能提高非色素性皮肤癌的诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a28114563b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680475, encodeId=ef2816804e536, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Am Acad Dermatol：性别和地域性紫外线指数之间的相互作用与黑色素瘤风险是否相关？, objectType=article, longId=122740, objectId=38ad122e408d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38ad122e408d, replyNumber=0, likeNumber=62, createdTime=2018-05-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38ad122e408d, moduleTitle=J Am Acad Dermatol：性别和地域性紫外线指数之间的相互作用与黑色素瘤风险是否相关？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38ad122e408d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680441, encodeId=e8b616804417d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：黑色素瘤治疗期间PD-L1表达改变可以预测PD-1治疗反应, objectType=article, longId=112126, objectId=95fc11212692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95fc11212692, replyNumber=0, likeNumber=106, createdTime=2017-11-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95fc11212692, moduleTitle=CLIN CANCER RES：黑色素瘤治疗期间PD-L1表达改变可以预测PD-1治疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95fc11212692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680447, encodeId=0ac7168044e65, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Am Acad Dermatol：使用靶向抗癌药物能促进患者的色素改变（Meta分析）, objectType=article, longId=113400, objectId=43e411340026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43e411340026, replyNumber=0, likeNumber=53, createdTime=2017-10-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43e411340026, moduleTitle=J Am Acad Dermatol：使用靶向抗癌药物能促进患者的色素改变（Meta分析）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43e411340026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680418, encodeId=dcf1168041868, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=BMJ：是痣还是黑色素瘤？诊断难度真的超乎你想象, objectType=article, longId=105309, objectId=2e5a105309a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e5a105309a0, replyNumber=0, likeNumber=68, createdTime=2018-03-26, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e5a105309a0, moduleTitle=BMJ：是痣还是黑色素瘤？诊断难度真的超乎你想象, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e5a105309a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680435, encodeId=2f80168043518, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JCO ：Nivolumab+Ipilimumab联合治疗黑色素瘤的疗效和安全性研究, objectType=article, longId=111056, objectId=508e111056bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508e111056bc, replyNumber=0, likeNumber=67, createdTime=2018-04-29, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508e111056bc, moduleTitle=JCO ：Nivolumab+Ipilimumab联合治疗黑色素瘤的疗效和安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508e111056bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680459, encodeId=cc911680459a4, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Am Acad Dermatol：黑色素瘤自诊工具——ABCDE原则和丑小鸭征, objectType=article, longId=118292, objectId=f92e118292aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f92e118292aa, replyNumber=0, likeNumber=63, createdTime=2018-05-06, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f92e118292aa, moduleTitle=J Am Acad Dermatol：黑色素瘤自诊工具——ABCDE原则和丑小鸭征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f92e118292aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680455, encodeId=7c3a168045504, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NCCN临床实践指南：黑色素瘤（2018.V1）, objectType=article, longId=117265, objectId=c60611e26577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c60611e26577, replyNumber=0, likeNumber=21, createdTime=2018-04-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c60611e26577, moduleTitle=NCCN临床实践指南：黑色素瘤（2018.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c60611e26577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680425, encodeId=6ae41680425a0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Int Ophthalmol. : 在色素性视网膜炎患者中植入艾哈迈德青光眼瓣膜可以解决由于类固醇引起的眼内压升高的后果！, objectType=article, longId=106717, objectId=68fa106e1739, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68fa106e1739, replyNumber=0, likeNumber=65, createdTime=2018-01-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68fa106e1739, moduleTitle=Int Ophthalmol. : 在色素性视网膜炎患者中植入艾哈迈德青光眼瓣膜可以解决由于类固醇引起的眼内压升高的后果！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68fa106e1739)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680422, encodeId=eb93168042213, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Am Acad Dermatol：良性肢端黑色素瘤的临床病理学特征有哪些？在成人和儿童患者中有何区别？, objectType=article, longId=105474, objectId=53161054e416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53161054e416, replyNumber=0, likeNumber=50, createdTime=2018-03-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53161054e416, moduleTitle=J Am Acad Dermatol：良性肢端黑色素瘤的临床病理学特征有哪些？在成人和儿童患者中有何区别？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53161054e416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680397, encodeId=b687168039ece, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：足底黑色素瘤-案例报道, objectType=article, longId=98471, objectId=4131984e185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4131984e185, replyNumber=0, likeNumber=91, createdTime=2017-05-24, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4131984e185, moduleTitle=NEJM：足底黑色素瘤-案例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4131984e185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680385, encodeId=d9fe16803851a, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=恶性黑色素瘤靶向治疗的研究进展, objectType=article, longId=91798, objectId=5cf591e9847, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cf591e9847, replyNumber=0, likeNumber=70, createdTime=2017-12-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cf591e9847, moduleTitle=恶性黑色素瘤靶向治疗的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cf591e9847)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680390, encodeId=a947168039004, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JAMA Surg：黑色素瘤腹部转移的治疗与生存率：1969-2014, objectType=article, longId=95056, objectId=8d4e95056bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4e95056bf, replyNumber=0, likeNumber=71, createdTime=2017-08-17, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4e95056bf, moduleTitle=JAMA Surg：黑色素瘤腹部转移的治疗与生存率：1969-2014, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d4e95056bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680469, encodeId=c437168046905, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：肢端黑色素瘤CDK4通路基因改变表明CDK4/6抑制可以作为靶向疗法, objectType=article, longId=121178, objectId=6c591211e82d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c591211e82d, replyNumber=0, likeNumber=86, createdTime=2018-06-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c591211e82d, moduleTitle=CLIN CANCER RES：肢端黑色素瘤CDK4通路基因改变表明CDK4/6抑制可以作为靶向疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c591211e82d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Nature：PD-1免疫疗法再掀高潮！罕见黑色素瘤完全缓解近1/3！

2018-09-11

sunylz (审核中...)

前往app查看评论内容

#色素#

Eur J Ophthalmol：双侧色素黄斑病和前段发育不良的罕见病例！

2018-03-20

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：黑色素瘤PD-L1表达：不同免疫组化抗体间的比较

2017-12-29

sunylz (审核中...)

前往app查看评论内容

#色素#

BJC：鼻腔粘膜黑色素瘤治疗新手段！

2018-01-17

sunylz (审核中...)

前往app查看评论内容

#色素#

Transl Oncol：BTYNB或是黑色素瘤和卵巢癌新的治疗靶点

2017-10-11

sunylz (审核中...)

前往app查看评论内容

#色素#

EUR J Cancer：Pembrolizumab治疗晚期黑色素瘤后使用伊匹单抗/nivolumab治疗的风险较低

2018-03-05

sunylz (审核中...)

前往app查看评论内容

#色素#

J Am Acad Dermatol：皮肤镜能提高非色素性皮肤癌的诊断和管理

2017-12-25

sunylz (审核中...)

前往app查看评论内容

#色素#

J Am Acad Dermatol：性别和地域性紫外线指数之间的相互作用与黑色素瘤风险是否相关？

2018-05-01

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：黑色素瘤治疗期间PD-L1表达改变可以预测PD-1治疗反应

2017-11-28

sunylz (审核中...)

前往app查看评论内容

#色素#

J Am Acad Dermatol：使用靶向抗癌药物能促进患者的色素改变（Meta分析）

2017-10-28

heli0118 (审核中...)

前往app查看评论内容

#色素#

BMJ：是痣还是黑色素瘤？诊断难度真的超乎你想象

2018-03-26

sunylz (审核中...)

前往app查看评论内容

#色素#

JCO ：Nivolumab+Ipilimumab联合治疗黑色素瘤的疗效和安全性研究

2018-04-29

sunylz (审核中...)

前往app查看评论内容

#色素#

J Am Acad Dermatol：黑色素瘤自诊工具——ABCDE原则和丑小鸭征

2018-05-06

sunylz (审核中...)

前往app查看评论内容

#色素#

NCCN临床实践指南：黑色素瘤（2018.V1）

2018-04-16

sunylz (审核中...)

前往app查看评论内容

#色素#

Int Ophthalmol. : 在色素性视网膜炎患者中植入艾哈迈德青光眼瓣膜可以解决由于类固醇引起的眼内压升高的后果！

2018-01-31

sunylz (审核中...)

前往app查看评论内容

#色素#

J Am Acad Dermatol：良性肢端黑色素瘤的临床病理学特征有哪些？在成人和儿童患者中有何区别？

2018-03-09

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：足底黑色素瘤-案例报道

2017-05-24

sunylz (审核中...)

前往app查看评论内容

#色素#

恶性黑色素瘤靶向治疗的研究进展

2017-12-04

sunylz (审核中...)

前往app查看评论内容

#色素#

JAMA Surg：黑色素瘤腹部转移的治疗与生存率：1969-2014

2017-08-17

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：肢端黑色素瘤CDK4通路基因改变表明CDK4/6抑制可以作为靶向疗法

2018-06-12

科室
- - 订阅+
  - 更多科室
工具
服务